Company: PFSA
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076861
Chunk: 1

Company: Profusa, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
 stock subject to possible redemption, 101,777 and 687,519 shares at redemption value of approximately $13.07 and $12.13 at June 30, 2025 and December 31, 2024, respectively 
     1,330,515  
     8,337,388 

    Stockholders’ Deficit: 

    Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding 
     —  
     — 
  
    Common stock, $0.0001 par value; 100,000,000 shares authorized; 5,193,750 shares issued and outstanding at June 30, 2025 and December 31, 2024 (excluding 101,777 and 687,519 shares subject to possible redemption at June 30, 2025 and December 31, 2024, respectively) 
     519  
     519 
  
    Accumulated deficit 
     (22,510,739) 
     (12,957,266)
  
    Total Stockholders’ Deficit 
     (22,510,220) 
     (12,956,747)
  
    Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit 
    $1,962,416  
    $8,391,697 

The accompanying notes are an integral part of
the unaudited condensed consolidated financial statements.

1

PROFUSA, INC. (F/K/A NORTHVIEW ACQUISITION
CORPORATION)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF OPERATIONS

    For the Three Months Ended June 30,  
    For the Six Months Ended June 30, 

    2025  
    2024  
    2025  
    2024 
  
    Formation and operating costs 
    $967,084  
    $253,130  
    $1,550,665  
    $723,971 
  
    Loss from operations 
     (967,084) 
     (253,130) 
     (1,550,665) 
     (723,971)

    Other (expense) income: 

    Interest income earned on cash held in Trust Account 
     15,159  
     108,520